Description

Nimodipin (Nimodipine) Coated Tablets 0.03 №30

Ingredients:

Each coated tablet contains 30 mg of Nimodipine.

Dosage:

The usual dose is 60 mg (2 tablets) every 4 hours, not to exceed 360 mg in 24 hours.

Indications:

Nimodipine is indicated for the improvement of neurological outcome by reducing the severity of ischemic deficits in patients with subarachnoid hemorrhage.

Contraindications:

Do not use Nimodipine if you are allergic to calcium channel blockers.

Directions:

Take Nimodipine exactly as prescribed by your doctor. Do not crush or chew the tablets.

Scientific Evidence:

Nimodipine, a dihydropyridine calcium channel blocker, has shown promising results in improving outcomes in patients with subarachnoid hemorrhage. Studies have demonstrated its ability to prevent cerebral vasospasm and improve cerebral blood flow, ultimately leading to better neurological outcomes.

Additional Information:

Nimodipine is well-tolerated in most patients, with common side effects including hypotension and headache. It is important to monitor blood pressure regularly during treatment with Nimodipine. Consult your healthcare provider for more information on the use of this medication.

Research has also suggested that Nimodipine may have neuroprotective effects beyond its vasodilatory properties, making it a promising drug in the treatment of various neurological conditions.